We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
176
Achmea Investment Management
Netherlands
$1.73M -$576K -4,533 -28%
Nomura Holdings
177
Nomura Holdings
Japan
$1.72M +$609K +4,791 +70%
KBC Group
178
KBC Group
Belgium
$1.71M -$1.45M -11,444 -50%
HP
179
Hikari Power
Japan
$1.7M – – –
XK
180
Xact Kapitalforvaltning
Sweden
$1.7M +$53.9K +424 +4%
Mackenzie Financial
181
Mackenzie Financial
Ontario, Canada
$1.69M +$1.45M +11,423 New
LAM
182
Lingohr Asset Management
Germany
$1.67M +$45K +354 +3%
SAM
183
Shell Asset Management
Netherlands
$1.61M -$670K -5,269 -33%
LSERS
184
Louisiana State Employees Retirement System
Louisiana
$1.61M -$89K -700 -6%
NMERB
185
New Mexico Educational Retirement Board
New Mexico
$1.6M +$1.37M +10,800 New
AIC
186
Aurora Investment Counsel
Georgia
$1.56M +$1.34M +10,571 New
NA
187
Neuburgh Advisers
California
$1.5M +$497K +3,910 +63%
SG Americas Securities
188
SG Americas Securities
New York
$1.49M -$91.9K -723 -7%
HSA
189
Hussman Strategic Advisors
Maryland
$1.48M -$1.91M -15,000 -60%
SGA
190
Strategic Global Advisors
California
$1.48M -$48.3K -380 -4%
WGCA
191
Wolf Group Capital Advisors
Virginia
$1.47M -$296K -2,331 -19%
TRSOTSOK
192
Teachers Retirement System of the State of Kentucky
Kentucky
$1.46M – – –
BA
193
Boston Advisors
Massachusetts
$1.45M -$73.7K -580 -6%
CCG
194
Chatham Capital Group
Georgia
$1.43M +$10.2K +80 +0.8%
Thrivent Financial for Lutherans
195
Thrivent Financial for Lutherans
Minnesota
$1.38M -$1.14K -9 -0.1%
Wellington Management Group
196
Wellington Management Group
Massachusetts
$1.37M -$65.8K -518 -5%
HW
197
Hancock Whitney
Mississippi
$1.33M +$19.4K +153 +2%
EF
198
Empirical Finance
Pennsylvania
$1.32M -$853K -6,712 -43%
Franklin Resources
199
Franklin Resources
California
$1.32M +$558K +4,389 +98%
FDCDDQ
200
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.3M +$28.6K +225 +3%
6 7
8
9 10

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.